{"id":4215,"date":"2021-03-25T07:48:00","date_gmt":"2021-03-25T07:48:00","guid":{"rendered":"https:\/\/www.ihu-liryc.fr\/first-commercially-approved-use-of-pulsed-field-ablation\/"},"modified":"2023-02-03T09:40:38","modified_gmt":"2023-02-03T09:40:38","slug":"first-commercially-approved-use-of-pulsed-field-ablation","status":"publish","type":"post","link":"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/","title":{"rendered":"FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION"},"content":{"rendered":"\n<p>LIRYC CONTINUES TRADITION OF INNOVATION WITH FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION TECHNOLOGY TO TREAT PATIENT WITH ATRIAL FIBRILLATION<\/p>\n\n<p><br\/>On March 23rd, 2021, Pierre Ja\u00efs and his team performed the world\u2019s first procedure using a CE Mark-approved PFA system on a patient with atrial fibrillation (AF).\u00a0 The procedure was performed in Bordeaux, France using technology from FARAPULSE, Inc. at the Bordeaux University Hospital.<\/p>\n<smartfire-component name='spacer' attributes=\"{&quot;height&quot;:50,&quot;laptopHeight&quot;:45,&quot;tabletHeight&quot;:40,&quot;mobileHeight&quot;:30}\"><\/smartfire-component><smartfire-component name='citation' attributes=\"{&quot;image&quot;:{&quot;id&quot;:1711,&quot;title&quot;:&quot;22 02 Retour sur l\\u2019allocution du Pr Pierre Jai\\u0308s, a\\u0300 l\\u2019occasion de la ce\\u0301re\\u0301monie de v\\u0153ux Pierre Jais _@Marie Astrid Jamois - juiillet 2020 (9)&quot;,&quot;filename&quot;:&quot;22-02-Retour-sur-lallocution-du-Pr-Pierre-Jai\\u0308s-a\\u0300-loccasion-de-la-ce\\u0301re\\u0301monie-de-voeux-Pierre-Jais-_@Marie-Astrid-Jamois-juiillet-2020-9.jpg&quot;,&quot;url&quot;:&quot;https:\\\/\\\/ihu-liryc.fr\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/22-02-Retour-sur-lallocution-du-Pr-Pierre-Jai\\u0308s-a\\u0300-loccasion-de-la-ce\\u0301re\\u0301monie-de-voeux-Pierre-Jais-_@Marie-Astrid-Jamois-juiillet-2020-9.jpg&quot;,&quot;link&quot;:&quot;https:\\\/\\\/ihu-liryc.fr\\\/?attachment_id=1711&quot;,&quot;alt&quot;:&quot;&quot;,&quot;author&quot;:&quot;10&quot;,&quot;description&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;name&quot;:&quot;22-02-retour-sur-lallocution-du-pr-pierre-jai%cc%88s-a-loccasion-de-la-ceremonie-de-voeux-pierre-jais-_marie-astrid-jamois-juiillet-2020-9&quot;,&quot;status&quot;:&quot;inherit&quot;,&quot;uploadedTo&quot;:1710,&quot;date&quot;:&quot;2022-12-11T07:49:43.000Z&quot;,&quot;modified&quot;:&quot;2022-12-11T07:49:43.000Z&quot;,&quot;menuOrder&quot;:0,&quot;mime&quot;:&quot;image\\\/jpeg&quot;,&quot;type&quot;:&quot;image&quot;,&quot;subtype&quot;:&quot;jpeg&quot;,&quot;icon&quot;:&quot;https:\\\/\\\/ihu-liryc.fr\\\/wp-includes\\\/images\\\/media\\\/default.png&quot;,&quot;dateFormatted&quot;:&quot;11 d\\u00e9cembre 2022&quot;,&quot;nonces&quot;:{&quot;update&quot;:&quot;1dbfab3f95&quot;,&quot;delete&quot;:&quot;a29c95f6f0&quot;,&quot;edit&quot;:&quot;e7340f6b69&quot;},&quot;editLink&quot;:&quot;https:\\\/\\\/ihu-liryc.fr\\\/wp-admin\\\/post.php?post=1711&amp;action=edit&amp;lang=fr&quot;,&quot;meta&quot;:false,&quot;authorName&quot;:&quot;jeanguy&quot;,&quot;authorLink&quot;:&quot;https:\\\/\\\/ihu-liryc.fr\\\/wp-admin\\\/profile.php&quot;,&quot;uploadedToTitle&quot;:&quot;Retour sur l\\u2019allocution du Pr Pierre Ja\\u00efs, \\u00e0 l\\u2019occasion de la c\\u00e9r\\u00e9monie de v\\u0153ux&quot;,&quot;uploadedToLink&quot;:&quot;https:\\\/\\\/ihu-liryc.fr\\\/wp-admin\\\/post.php?post=1710&amp;action=edit&amp;lang=fr&quot;,&quot;filesizeInBytes&quot;:413054,&quot;filesizeHumanReadable&quot;:&quot;403 Ko&quot;,&quot;context&quot;:&quot;&quot;,&quot;height&quot;:1001,&quot;width&quot;:1500,&quot;orientation&quot;:&quot;landscape&quot;,&quot;sizes&quot;:{&quot;full&quot;:{&quot;url&quot;:&quot;https:\\\/\\\/ihu-liryc.fr\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/22-02-Retour-sur-lallocution-du-Pr-Pierre-Jai\\u0308s-a\\u0300-loccasion-de-la-ce\\u0301re\\u0301monie-de-voeux-Pierre-Jais-_@Marie-Astrid-Jamois-juiillet-2020-9.jpg&quot;,&quot;height&quot;:1001,&quot;width&quot;:1500,&quot;orientation&quot;:&quot;landscape&quot;}},&quot;compat&quot;:{&quot;item&quot;:&quot;&quot;,&quot;meta&quot;:&quot;&quot;},&quot;acf_errors&quot;:false},&quot;citation&quot;:&quot;&lt;br&gt;&lt;br&gt;&lt;br&gt;L&#039;ablation par \\u00e9lectroporation (PFA) repr\\u00e9sente une \\u00e9l\\u00e9vation monumentale de la norme de soins pour le traitement des patients souffrant de fibrillation auriculaire en minimisant la probabilit\\u00e9 de complications, rares mais bien r\\u00e9elles et bien d\\u00e9crites, telles que des dommages \\u00e0 l&#039;\\u0153sophage, aux nerfs et aux veines pulmonaires. Tout comme l&#039;introduction de la technique d&#039;isolation de la veine pulmonaire (PVI), mise au point dans cet institut il y a 23 ans, l&#039;\\u00e9lectroporation est en mesure d&#039;ouvrir une nouvelle \\u00e8re pour l&#039;ablation de la FA. Mon exp\\u00e9rience etay\\u00e9e par nos solides donn\\u00e9es, nous conduit \\u00e0 penser que l&#039;\\u00e9lectroporation semble \\u00eatre un outil sup\\u00e9rieur \\u00e0 l&#039;approche PVI pour traiter la FA.&quot;,&quot;author&quot;:&quot;Pr Pierre Ja\\u00efs&quot;,&quot;role&quot;:&quot;Directeur G\\u00e9n\\u00e9ral de Liryc, Chef de l&#039;unit\\u00e9 d&#039;\\u00e9lectrophysiologie, CHU de Bordeaux&quot;}\"><\/smartfire-component><smartfire-component name='spacer' attributes=\"{&quot;height&quot;:50,&quot;laptopHeight&quot;:45,&quot;tabletHeight&quot;:40,&quot;mobileHeight&quot;:30}\"><\/smartfire-component><smartfire-component name='citation' attributes=\"{&quot;citation&quot;:&quot;&lt;br&gt;&lt;br&gt;&lt;br&gt;FARAPULSE est honor\\u00e9 de travailler aux c\\u00f4t\\u00e9s de Liryc et du professeur Ja\\u00efs, qui ont jou\\u00e9 un r\\u00f4le d\\u00e9terminant dans le perfectionnement et la confirmation du potentiel de notre syst\\u00e8me cardiaque d&#039;\\u00e9lectroportation. En faisant progresser cette plateforme de pointe et en l&#039;aidant \\u00e0 se diriger vers la commercialisation, l&#039;institut remplit une fois de plus sa mission importante qui est d&#039;innover pour am\\u00e9liorer les soins.&quot;,&quot;author&quot;:&quot;Allan Zingeler&quot;,&quot;role&quot;:&quot;Pr\\u00e9sident Directeur G\\u00e9n\\u00e9ral de FARAPULSE&quot;}\"><\/smartfire-component><smartfire-component name='spacer' attributes=\"{&quot;height&quot;:50,&quot;laptopHeight&quot;:45,&quot;tabletHeight&quot;:40,&quot;mobileHeight&quot;:30}\"><\/smartfire-component>\n<p><strong>About FARAPULSE and PFA<\/strong>&#13;\n<br\/>Today, all forms of cardiac ablation to treat arrhythmias are thermal. While both radiofrequency and cryo-ablation have evolved, they nonetheless carry an inherent risk of indiscriminate thermal damage. Tissue-selective FARAPULSE PFA has emerged to be one of the most promising energy sources for cardiac ablation, including pulmonary vein isolation to treat Atrial Fibrillation. Leading with safety, FARAPULSE PFA makes durable cardiac lesions in seconds while sparing non-target tissue.\u00a0As a reminder, PEF uses high-voltage electric microshocks to creates nanoscale pores in cell membranes FARAPULSE is pioneering tissue-selective PFA therapy through development and commercialization of its dedicated generator (FARASTAR), PVI-focused catheter (FARAWAVE), large-area focal catheter (FARAFLEX), precision focal catheter (FARAPOINT) and a proprietary deflectable delivery sheath (FARADRIVE). The FARAPULSE PFA system, which includes FARAWAVE, FARASTAR and FARADRIVE, received CE mark approval in January 2021 and is commercially available across Europe.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>LIRYC CONTINUES TRADITION OF INNOVATION WITH FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION TECHNOLOGY TO TREAT PATIENT WITH ATRIAL FIBRILLATION On March 23rd, 2021, Pierre Ja\u00efs and his team performed the world\u2019s first procedure using a CE Mark-approved PFA system on a patient with atrial fibrillation (AF).\u00a0 The procedure was performed in Bordeaux, France [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":1904,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27],"tags":[],"class_list":["post-4215","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION - IHU Liryc<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION - IHU Liryc\" \/>\n<meta property=\"og:description\" content=\"LIRYC CONTINUES TRADITION OF INNOVATION WITH FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION TECHNOLOGY TO TREAT PATIENT WITH ATRIAL FIBRILLATION On March 23rd, 2021, Pierre Ja\u00efs and his team performed the world\u2019s first procedure using a CE Mark-approved PFA system on a patient with atrial fibrillation (AF).\u00a0 The procedure was performed in Bordeaux, France [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/\" \/>\n<meta property=\"og:site_name\" content=\"IHU Liryc\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-25T07:48:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-03T09:40:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ihu-liryc.fr\/wp-content\/uploads\/2022\/12\/premiere-approbation-farapusle.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1438\" \/>\n\t<meta property=\"og:image:height\" content=\"790\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"jeanguy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"jeanguy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/\",\"url\":\"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/\",\"name\":\"FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION - IHU Liryc\",\"isPartOf\":{\"@id\":\"https:\/\/www.ihu-liryc.fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ihu-liryc.fr\/wp-content\/uploads\/2022\/12\/premiere-approbation-farapusle.jpg\",\"datePublished\":\"2021-03-25T07:48:00+00:00\",\"dateModified\":\"2023-02-03T09:40:38+00:00\",\"author\":{\"@id\":\"https:\/\/www.ihu-liryc.fr\/#\/schema\/person\/064274d1dad63780037e10b4b3a95e34\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/#primaryimage\",\"url\":\"https:\/\/www.ihu-liryc.fr\/wp-content\/uploads\/2022\/12\/premiere-approbation-farapusle.jpg\",\"contentUrl\":\"https:\/\/www.ihu-liryc.fr\/wp-content\/uploads\/2022\/12\/premiere-approbation-farapusle.jpg\",\"width\":1438,\"height\":790},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ihu-liryc.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ihu-liryc.fr\/#website\",\"url\":\"https:\/\/www.ihu-liryc.fr\/\",\"name\":\"IHU Liryc\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ihu-liryc.fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ihu-liryc.fr\/#\/schema\/person\/064274d1dad63780037e10b4b3a95e34\",\"name\":\"jeanguy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ihu-liryc.fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/102512963f18fa4354576b9dca79eeacfa9c0832d0e510afab42e07fae790007?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/102512963f18fa4354576b9dca79eeacfa9c0832d0e510afab42e07fae790007?s=96&d=mm&r=g\",\"caption\":\"jeanguy\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION - IHU Liryc","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/","og_locale":"en_US","og_type":"article","og_title":"FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION - IHU Liryc","og_description":"LIRYC CONTINUES TRADITION OF INNOVATION WITH FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION TECHNOLOGY TO TREAT PATIENT WITH ATRIAL FIBRILLATION On March 23rd, 2021, Pierre Ja\u00efs and his team performed the world\u2019s first procedure using a CE Mark-approved PFA system on a patient with atrial fibrillation (AF).\u00a0 The procedure was performed in Bordeaux, France [&hellip;]","og_url":"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/","og_site_name":"IHU Liryc","article_published_time":"2021-03-25T07:48:00+00:00","article_modified_time":"2023-02-03T09:40:38+00:00","og_image":[{"width":1438,"height":790,"url":"https:\/\/www.ihu-liryc.fr\/wp-content\/uploads\/2022\/12\/premiere-approbation-farapusle.jpg","type":"image\/jpeg"}],"author":"jeanguy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"jeanguy","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/","url":"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/","name":"FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION - IHU Liryc","isPartOf":{"@id":"https:\/\/www.ihu-liryc.fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/#primaryimage"},"image":{"@id":"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ihu-liryc.fr\/wp-content\/uploads\/2022\/12\/premiere-approbation-farapusle.jpg","datePublished":"2021-03-25T07:48:00+00:00","dateModified":"2023-02-03T09:40:38+00:00","author":{"@id":"https:\/\/www.ihu-liryc.fr\/#\/schema\/person\/064274d1dad63780037e10b4b3a95e34"},"breadcrumb":{"@id":"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/#primaryimage","url":"https:\/\/www.ihu-liryc.fr\/wp-content\/uploads\/2022\/12\/premiere-approbation-farapusle.jpg","contentUrl":"https:\/\/www.ihu-liryc.fr\/wp-content\/uploads\/2022\/12\/premiere-approbation-farapusle.jpg","width":1438,"height":790},{"@type":"BreadcrumbList","@id":"https:\/\/www.ihu-liryc.fr\/en\/first-commercially-approved-use-of-pulsed-field-ablation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ihu-liryc.fr\/en\/"},{"@type":"ListItem","position":2,"name":"FIRST COMMERCIALLY APPROVED USE OF PULSED FIELD ABLATION"}]},{"@type":"WebSite","@id":"https:\/\/www.ihu-liryc.fr\/#website","url":"https:\/\/www.ihu-liryc.fr\/","name":"IHU Liryc","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ihu-liryc.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.ihu-liryc.fr\/#\/schema\/person\/064274d1dad63780037e10b4b3a95e34","name":"jeanguy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ihu-liryc.fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/102512963f18fa4354576b9dca79eeacfa9c0832d0e510afab42e07fae790007?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102512963f18fa4354576b9dca79eeacfa9c0832d0e510afab42e07fae790007?s=96&d=mm&r=g","caption":"jeanguy"}}]}},"_links":{"self":[{"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/posts\/4215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/comments?post=4215"}],"version-history":[{"count":1,"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/posts\/4215\/revisions"}],"predecessor-version":[{"id":4216,"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/posts\/4215\/revisions\/4216"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/media\/1904"}],"wp:attachment":[{"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/media?parent=4215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/categories?post=4215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ihu-liryc.fr\/en\/wp-json\/wp\/v2\/tags?post=4215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}